Nat Rev Cancer. 2003 May;3(5):330-8.

5-fluorouracil: mechanisms of action and clinical strategies.

Source

Cancer Research Centre, Department of Oncology, Queen's University Belfast, University Floor, Belfast City Hospital, 97 Lisburn Road, Belfast BT9 7AB, Northern Ireland.

Abstract

5-fluorouracil (5-FU) is widely used in the treatment of cancer. Over the past 20 years, increased understanding of the mechanism of action of 5-FU has led to the development of strategies that increase its anticancer activity. Despite these advances, drug resistance remains a significant limitation to the clinical use of 5-FU. Emerging technologies, such as DNA microarray profiling, have the potential to identify novel genes that are involved in mediating resistance to 5-FU. Such target genes might prove to be therapeutically valuable as new targets for chemotherapy, or as predictive biomarkers of response to 5-FU-based chemotherapy.

PMID:: 12724731; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. [Int J Cancer. 2006]
Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R, Togo S, Shimizu D, Momiyama N, Ishikawa T, Ichikawa Y, Endo I, Kunisaki C, Suzuki H, Hayasizaki Y, et al. Int J Cancer. 2006 Jul 15; 119(2):406-13.
Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen. [Clin Cancer Res. 2001]
Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL, Danenberg KD, Behan K, Parr A, Young L, Danenberg PV, Nguyen D, Drake J, Monks A, Allegra CJ. Clin Cancer Res. 2001 Apr; 7(4):999-1009.
Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines. [J Gastroenterol. 2006]
Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines.
Miyazaki K, Shibahara T, Sato D, Uchida K, Suzuki H, Matsui H, Yanaka A, Nakahara A, Matsuzaki Y. J Gastroenterol. 2006 Feb; 41(2):140-50.
Review 5-Fluorouracil pharmacogenomics: still rocking after all these years? [Pharmacogenomics. 2011]
Review 5-Fluorouracil pharmacogenomics: still rocking after all these years?
Scartozzi M, Maccaroni E, Giampieri R, Pistelli M, Bittoni A, Del Prete M, Berardi R, Cascinu S. Pharmacogenomics. 2011 Feb; 12(2):251-65.
Review Clinical implications of dihydropyrimidine dehydrogenase on 5-FU pharmacology. [Oncology (Williston Park). 2001]
Review Clinical implications of dihydropyrimidine dehydrogenase on 5-FU pharmacology.
Diasio RB. Oncology (Williston Park). 2001 Jan; 15(1 Suppl 2):21-6; discussion 27.

See reviews... See all...

Cited by over 100 PubMed Central articles

A novel aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment. [Int J Biol Sci. 2013]
A novel aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment.
Shionome Y, Lin WH, Shiao HY, Hsieh HP, Hsu JT, Ouchi T. Int J Biol Sci. 2013; 9(4):403-11. Epub 2013 Apr 29.
Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer. [Per Med. 2011]
Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer.
Kim RY, Xu H, Myllykangas S, Ji H. Per Med. 2011 May 1; 8(3):331-345.
Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage. [Drug Deliv Transl Res. 2012]
Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage.
Penet MF, Chen Z, Li C, Winnard PT Jr, Bhujwalla ZM. Drug Deliv Transl Res. 2012 Feb 1; 2(1):22-30.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioSystems
Pathways and biological systems (BioSystems) that cite the current articles. Citations are from the BioSystems source databases (KEGG and BioCyc).
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

5-fluorouracil: mechanisms of action and clinical strategies.
5-fluorouracil: mechanisms of action and clinical strategies.
Nat Rev Cancer. 2003 May ;3(5):330-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

5-fluorouracil: mechanisms of action and clinical strategies.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by over 100 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information